Extension of the MDD Certificate for Our Medical Devices Supporting Women’s Wellness at Every Stage of Life The MDR Regulation, in effect since May 2017 and applicable from May 2021, governs medical devices in Europe. Deadline extensions allow the marketing of devices compliant with the Medical Device Directive (MDD) until December 31, 2027, for class…
Registration of a Medical Device in Oman: Vaginal Suppositories Based on Hyaluronic Acid, Lactic Acid, Triglycerides, and Polycarbophil We are pleased to announce the recent registration of a Class II medical device with the competent authorities in Oman. This milestone reflects our ongoing commitment to providing women’s health solutions in compliance with international standards. …
Registration of Class IIa Medical Device for Gastroesophageal Reflux at the Department of Health in Hanoi, Vietnam The Department of Health in Hanoi, Vietnam officially registered our Class IIa medical device. Additionally, it’s important to note that the device holds an MDD certificate extension. The device is an oral emulsion composed of key actives: low…
Effective vaginal relief: medical device registered in Vietnam for women’s well-being GFI proudly announces that we have successfully registered a Class IIa medical device in Vietnam, formulated with natural ingredients. This device is a vaginal ovule composed of hyaluronic acid, lactic acid, Centella Asiatica, calendula, chamomile, and tea tree oil. Indicated to addressing a wide…
Gruppo FarmaImpresa completes the registration process for an oral emulsion for Gastroesophageal Reflux Disease Treatment With pride, we present our recent success in obtaining registration for a Class IIa medical device in Vietnam. This device, based on low molecular weight hyaluronic acid, sodium alginate, myrrh extract, and simethicone, is indicated for the treatment of gastroesophageal…